Company Overview of Alnylam Pharmaceuticals, Inc.
Phillip A. Sharp Ph.D.
Co-Founder, Director, Member of the Scientific Advisory Board, Chairman of Science & Technology Committee and Member of Nominating & Corporate Governance Committee, Alnylam Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 10 Board Members in 10 different organizations across 9 different industries.|
See Board Relationships
300 Third StreetPhone: 617-551-8200
Cambridge, Massachusetts 02142
Board Members Memberships
Director and Member of Strategic Advisory Board
Co-Founder, Director, Member of the Scientific Advisory Board, Chairman of Science & Technology Committee and Member of Nominating & Corporate Governance Committee
Director, Member of Scientific Advisory Board and Chairman of Compensation Committee
University of Illinois-Urbana-Champaign
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Stanley T. Crooke M.D., Ph.D.||Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Chairman of Agenda Committee|
Ionis Pharmaceuticals, Inc.
|Edward M. Kaye M.D., Ph.D.||Chief Executive Officer, President, Chief Medical Officer and Director|
Sarepta Therapeutics, Inc.
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Executive Director|
Arbutus Biopharma Corporation
|Paul C. Grint M.D.||Chief Executive Officer, President and Director|
Regulus Therapeutics Inc.
|Douglas M. Fambrough III, Ph.D.||Co-Founder, Chief Executive Officer, President and Director|
Dicerna Pharmaceuticals, Inc.
|$490.0K||Compensation as of Fiscal Year 2015.|